Leukemia patients are helped by Syndax's new type of therapy

AdobeSANDIEGO—OneofthetoughestsubtypesofacuteleukemiainvolvesageneticalterationintheKMT2Agene.Manyca DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio




leisure time

author：entertainment    Page View：7548

Editor’s note: A livestream of the event is embedded below.

Enough talk about fairness, safety, and effectiveness. If we want AI systems to possess these attributes in health care, we have to test them with those goals in mind.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Radiology is caught between AI's potential and concern for patients
Next article： Peter Hotez and the public health issue of online harassment